X0202 SCHEDULE 13G/A 0002088344-25-000003 0002088344 XXXXXXXX LIVE 3 Common Stock, $0.0001 par value per share 06/30/2026 0001817229 VOR BIOPHARMA INC. 929033207 500 Boylston Street Suite 1350 Boston MA 02116 Rule 13d-1(c) Verve Capital Limited Y0 3410892.00 0.00 3410892.00 0.00 3410892.00 6.3 CO VOR BIOPHARMA INC. 500 Boylston Street, Suite 1350, Boston, MA, 02116. Verve Capital Limited Flat B, 23/F, Panorama Gardens, 103 Robinson Road, Mid-Levels, Hong Kong Samoa Y Row 9 of the Reporting Person's cover page to this Schedule 13G/A sets forth the aggregate number of shares of common stock of the Issuer (the "Shares") beneficially owned by such Reporting Person as of June 30, 2026 and is incorporated by reference. The percentage set forth in Row 11 of the cover page is calculated based upon 54,185,877 Shares outstanding as of May 7, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on May 13, 2026, plus 269,874 shares issued upon exercise of Pre-Funded Warrants by the Reporting Person on May 29, 2026. Verve Capital Limited: 6.3% Row 5 of the Reporting Person's cover page to this Schedule 13G/A sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by the Reporting Person as of June 30, 2026 and is incorporated by reference. Row 6 of the Reporting Person's cover page to this Schedule 13G/A sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by the Reporting Person as of June 30, 2026 and is incorporated by reference. Row 7 of the Reporting Person's cover page to this Schedule 13G/A sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by the Reporting Person as of June 30, 2026 and is incorporated by reference. Row 8 of the Reporting Person's cover page to this Schedule 13G/A sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by the Reporting Person as of June 30, 2026 and is incorporated by reference. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Verve Capital Limited /s/ Hongtu Zhu 08/13/2026